glucose, (beta-d)-isomer has been researched along with pf 04971729 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Babu, RJ; Dash, RP; Srinivas, NR | 1 |
| Abbate, A; Baker, WL; Brown, R; Bucheit, JD; Buckley, LF; Carbone, S; Dixon, DL; Kelly, MS; Parod, ED | 1 |
| Cutler, DL; Hickman, A; O'Gorman, M; Sahasrabudhe, V; Saur, D; Shi, H; Terra, SG; Zhou, Z | 1 |
| Forest, CP; Tat, V | 1 |
| Chan, YY; Chang, KC; Hung, MJ; Kao Yang, YH; Lai, EC; Lin, YH; Shao, SC | 1 |
| Chen, MB; Cui, WY; Wang, H; Xu, HL; Zheng, QH | 1 |
4 review(s) available for glucose, (beta-d)-isomer and pf 04971729
| Article | Year |
|---|---|
Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview.
Topics: Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Type 2; Glucosides; Half-Life; Humans; Hypoglycemic Agents; Pyrazoles; Sodium-Glucose Transporter 2 | 2017 |
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on 24-Hour Ambulatory Blood Pressure: A Systematic Review and Meta-Analysis.
Topics: Adult; Aged; Benzhydryl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bridged Bicyclo Compounds, Heterocyclic; Canagliflozin; Circadian Rhythm; Diabetes Mellitus; Female; Glucosides; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2017 |
The role of SGLT2 inhibitors in managing type 2 diabetes.
Topics: Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Canagliflozin; Diabetes Mellitus, Type 2; Glucose; Glucosides; Glycated Hemoglobin; Glycosuria; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Weight Loss | 2018 |
Effect of sodium-dependent glucose transporter inhibitors on glycated hemoglobin A1c after 24 weeks in patients with diabetes mellitus: A systematic review and meta-analysis.
Topics: Benzhydryl Compounds; Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Canagliflozin; Diabetes Mellitus, Type 2; Glucosides; Glycated Hemoglobin; Glycosides; Humans; Sodium-Glucose Transporter 2 Inhibitors; Time Factors | 2021 |
1 trial(s) available for glucose, (beta-d)-isomer and pf 04971729
| Article | Year |
|---|---|
The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus.
Topics: Aged; Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glucose; Glucosides; Humans; Hypoglycemic Agents; Kidney; Male; Middle Aged; Renal Insufficiency; Sodium-Glucose Transporter 2 | 2017 |
1 other study(ies) available for glucose, (beta-d)-isomer and pf 04971729
| Article | Year |
|---|---|
Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients?
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Canagliflozin; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glucosides; Glycated Hemoglobin; Humans; Male; Middle Aged; Observational Studies as Topic; Practice Patterns, Physicians'; Retrospective Studies; Sodium-Glucose Transporter 2 Inhibitors | 2019 |